A Study of Pevonedistat in Adult East Asian Participants

NCT02782468 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Myelodysplastic Syndromes

Interventions

DRUG: Pevonedistat 25 mg/m^2
DRUG: Pevonedistat 44 mg/m^2
DRUG: Pevonedistat 10 mg/m^2
DRUG: Pevonedistat 20 mg/m^2
DRUG: Azacitidine 75 mg/m^2

Sponsor

Millennium Pharmaceuticals, Inc.